Adjunctive corticosteroid improves eyesight in NAION
The addition of the corticosteroid fluocortolone to standard therapy significantly improves both short- and long-term visual acuity in patients with nonarteritic anterior ischemic optic neuropathy (NAION), according to a study in Restorative Neurology and Neuroscience.
In a prospective randomized trial of 60 patients with NAION, researchers from the Institute of Experimental Ophthalmology, University of Münster, Germany found that patients treated with pentoxifylline alone had no significant beneficial effects on either visual acuity or visual field after three days and six months of treatment. However, adding fluocortolone significantly more likely to experience improvement and less likely to have worsened visual acuity. After six months of therapy two thirds of patients treated with the combination therapy had better long-term vision compared to only 14 per cent of those only treated with pentoxifylline alone.
Details of the study appears in “Visual outcome of patients following NAION after treatment with adjunctive fluocortolone,” V. Prokosch et al. Restorative Neurology and Neuroscience, 2013. DOI 10.3233/RNN-120292.
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.